Metraipolis › archive › dc_f126dae276f7

Assessment of allopurinol use in patients with chronic kidney disease and asymptomatic hyperuricemia: a retrospective cohort study — Europe PMC PMID:42017921

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42017921
DOI
10.1590/2175-8239-jbn-2025-0243en
License (as archived)
solo-consultazione
Archived
2026-10-18T14:18:01.624Z
SHA-256 of the archived text
15abc7809ce89151b4427349b9837ba1091cf6464eb1a010eb0b9619a8afdedf
Stable URL of this page
https://metraipolis.com/documento/dc_f126dae276f7

How to cite

Assessment of allopurinol use in patients with chronic kidney disease and asymptomatic hyperuricemia: a retrospective cohort study — Europe PMC PMID:42017921 — Europe PMC (en), https://europepmc.org/article/MED/42017921 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_f126dae276f7 (Metraipolis archive dc_f126dae276f7, sha256 15abc7809ce89151b4427349b9837ba1091cf6464eb1a010eb0b9619a8afdedf)
BibTeX
@misc{dcf126dae276f7,
  title = {Assessment of allopurinol use in patients with chronic kidney disease and asymptomatic hyperuricemia: a retrospective cohort study — Europe PMC PMID:42017921},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42017921},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_f126dae276f7; sha256 15abc7809ce89151b4427349b9837ba1091cf6464eb1a010eb0b9619a8afdedf},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42017921. Agents can read the archived copy with the MCP tool read_document.